November 11, 2008Crestor research results lifesaving - Philadelphia Inquirer Crestor research results lifesaving - Philadelphia Inquirer
They are the kind of results that a drug company prays for: a 54 percent reduction in heart attacks for patients taking AstraZeneca P.L.C.'s Crestor compared with a placebo. A 44 percent reduction in heart problems, such as stroke. But it's far from Source: www.philly.com (Adds researcher comments, details on trial, Abbott strategy) - Reuters NEW ORLEANS, Nov 11 (Reuters) - Abbott Laboratories Inc's (ABT.N: Quote , Profile , Research , Stock Buzz ) experimental drug TriLipix was able to improve cholesterol and triglyceride levels significantly in patients for a year after earlier three Source: www.reuters.com Human-Cell Coating Helps Stent Without Blood Thinner (Update1) - Bloomberg Nov. 11 (Bloomberg) -- A heart stent that coats itself with human tissue kept arteries open without patients needing to take anti-clotting medications, a study found. The stent, made by closely held OrbusNeich , offers an alternative to drug-coated Source: www.bloomberg.com # posted by Network @ 1:00 PM
 |
Subscribe to Posts [Atom]